State Street Corp Iovance Biotherapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 13,201,978 shares of IOVA stock, worth $120 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,201,978

Previous 12,625,177 4.57%

Holding current value

$120 Million

Previous $101 Million 22.43%

% of portfolio

0.01%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.28 - $11.9 $4.2 Million - $6.86 Million	576,801 Added 4.57%	13,201,978 $124 Million
Q2 2024 Aug 14, 2024	BUY	$7.78 - $14.19 $17.3 Million - $31.5 Million	2,222,458 Added 21.36%	12,625,177 $101 Million
Q1 2024 May 15, 2024	SELL	$7.59 - $17.47 $45.7 Million - $105 Million	-6,021,669 Reduced 36.66%	10,402,719 $154 Million
Q4 2023 Feb 14, 2024	SELL	$3.3 - $8.89 $1.02 Million - $2.74 Million	-307,881 Reduced 1.84%	16,424,388 $134 Million
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $14.1 Million - $27.8 Million	3,166,471 Added 23.34%	16,732,269 $76.1 Million
Q2 2023 Aug 14, 2023	SELL	$5.36 - $9.06 $896,379 - $1.52 Million	-167,235 Reduced 1.22%	13,565,798 $95.5 Million
Q1 2023 May 15, 2023	SELL	$5.53 - $8.22 $5.43 Million - $8.08 Million	-982,442 Reduced 6.68%	13,733,033 $83.9 Million
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $26.9 Million - $47.8 Million	4,783,323 Added 48.16%	14,715,475 $94 Million
Q3 2022 Nov 15, 2022	SELL	$9.53 - $13.11 $17.5 Million - $24.1 Million	-1,838,599 Reduced 15.62%	9,932,152 $95.2 Million
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $31.4 Million - $90.3 Million	4,925,025 Added 71.94%	11,770,751 $130 Million
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $21.7 Million - $33.5 Million	1,752,044 Added 34.4%	6,845,726 $114 Million
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $11.7 Million - $19.5 Million	705,576 Added 16.08%	5,093,682 $97.2 Million
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $9.06 Million - $11.9 Million	445,433 Added 11.3%	4,388,106 $108 Million
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $14.2 Million - $28.7 Million	867,022 Added 28.19%	3,942,673 $103 Million
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $5.12 Million - $9.39 Million	178,572 Added 6.16%	3,075,651 $97.4 Million
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $7.64 Million - $13.7 Million	-272,482 Reduced 8.6%	2,897,079 $134 Million
Q3 2020 Nov 10, 2020	SELL	$27.75 - $36.3 $6.47 Million - $8.46 Million	-233,112 Reduced 6.85%	3,169,561 $104 Million
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $27.1 Million - $40.8 Million	-995,498 Reduced 22.63%	3,402,673 $93.4 Million
Q1 2020 May 11, 2020	BUY	$19.54 - $38.85 $85.9 Million - $171 Million	4,398,171 New	4,398,171 $132 Million

Others Institutions Holding IOVA

# of Institutions

314

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.43B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Iovance Biotherapeutics, Inc. Transaction History